TY - JOUR
T1 - Changes in diet, weight, and serum lipid levels associated with olestra consumption
AU - Patterson, Ruth E.
AU - Kristal, Alan R.
AU - Peters, John C.
AU - Neuhouser, Marian L.
AU - Rock, Cheryl L.
AU - Cheskin, Lawrence J
AU - Neumark-Sztainer, Dianne
AU - Thornquist, Mark D.
PY - 2000/9/25
Y1 - 2000/9/25
N2 - Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.
AB - Background: Specially manufactured low-fat and non-fat foods have become increasingly available over the past 2 decades and controversy has surrounded the issue of whether these products have beneficial or adverse effects on the health and nutritional status of Americans. Methods: This study examines the association of olestra consumption with changes in dietary intakes of energy, fat, and cholesterol and changes in weight and serum lipid concentrations. Data are from a cohort of 335 participants in the Olestra Post-Marketing Surveillance Study sentinel site in Marion County (Indianapolis, Ind). Diet, weight, and serum lipid levels were assessed before the market release of olestra and 1 year later, after olestra-containing foods were widely available. Olestra intake at the 1-year follow-up was categorized as none, low (>0 to 0.4 g/d), moderate (0.4 to 2.0 g/d), and heavy (>2.0 g/d). Results: Participants in the heavy olestra consumption category significantly reduced dietary intake of percentage of energy from fat (2.7 percentage points, P for trend, .003) and saturated fat (1.1 percentage points, P for trend, .02). Consumers in the highest category of olestra consumption had statistically significantly reduced total serum cholesterol levels of -0.54 mmol/L (-21 mg/dL) compared with -0.14 mmol/L (-5 mg/dL) among olestra nonconsumers (P for trend, .03). Conclusions: These results indicate that introduction of a new fat substitute (olestra) in the US market was associated with healthful changes in dietary fat intake and serum cholesterol concentrations among consumers who chose to consume olestra-containing foods.
UR - http://www.scopus.com/inward/record.url?scp=0034715305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034715305&partnerID=8YFLogxK
M3 - Article
C2 - 10999973
AN - SCOPUS:0034715305
SN - 0003-9926
VL - 160
SP - 2600
EP - 2604
JO - Archives of Internal Medicine
JF - Archives of Internal Medicine
IS - 17
ER -